# Theravance Biopharma, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:a60efba0-8d4c-4112-abee-20c3b113c86f | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/theravance-biopharma-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 14 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-05T04:47:43.645891+00:00 | | Last reviewed | 2026-10-05T04:47:43.645891+00:00 | ## Identity - Legal name: Theravance Biopharma, Inc. - Display name: Theravance Biopharma, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-21T08:35:39.500645+00:00 | | Completeness | 0.364 | | Record Quality | 0.847 | | Directors | 5 | | Committees | 0 | | Governance events | 10 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Dean J. Mitchell: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2014-01-01. claim_id=alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:5 - Deepika R. Pakianathan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:6 - Donal O’Connor: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2015-01-01. claim_id=alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:7 - Laurie Smaldone Alsup: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:8 - Susannah Gray: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:9 ## Executive leadership - Alan B. Miller: Senior Vice President, Development and Head of Ireland Office. Status: current. claim_id=alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:10 - Aziz Sawaf: Senior Vice President, Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:11 - Brett A. Grimaud: Senior Vice President, General Counsel and Secretary [GC]. Status: current. claim_id=alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:12 - Rhonda F. Farnum: Chief Business Officer and Senior Vice President, Commercial Medical Affairs. Status: current. claim_id=alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:13 - Rick E Winningham: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:14 ## Governance events - EXECUTIVE_APPOINTED: Alan B. Miller executive of Theravance Biopharma, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-05T04:47:43.645891+00:00. event_id=alpha:event:transition:17bpowsnmypvk - CFO_CHANGED: Aziz Sawaf executive of Theravance Biopharma, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-05T04:47:43.645891+00:00. event_id=alpha:event:transition:nigxbegxb48 - GC_CHANGED: Brett A. Grimaud executive of Theravance Biopharma, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-05T04:47:43.645891+00:00. event_id=alpha:event:transition:14z2j1e1v7fthk - EXECUTIVE_APPOINTED: Rhonda F. Farnum executive of Theravance Biopharma, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-05T04:47:43.645891+00:00. event_id=alpha:event:transition:10x4lp0my6czs - CEO_CHANGED: Rick E Winningham executive of Theravance Biopharma, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-05T04:47:43.645891+00:00. event_id=alpha:event:transition:ia4im81w3mhzg - DIRECTOR_APPOINTED: Susannah Gray seat on Theravance Biopharma, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-05T04:47:43.645891+00:00. event_id=alpha:event:transition:18zu5k6192kel0 - DIRECTOR_APPOINTED: Deepika R. Pakianathan seat on Theravance Biopharma, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-05T04:47:43.645891+00:00. event_id=alpha:event:transition:1jveml8owyf9o - DIRECTOR_APPOINTED: Laurie Smaldone Alsup seat on Theravance Biopharma, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-05T04:47:43.645891+00:00. event_id=alpha:event:transition:t21ypn18blpcd - DIRECTOR_APPOINTED: Donal O’Connor seat on Theravance Biopharma, Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-05T04:47:43.645891+00:00. event_id=alpha:event:transition:1cpeigxj76qk7 - DIRECTOR_APPOINTED: Dean J. Mitchell seat on Theravance Biopharma, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-05T04:47:43.645891+00:00. event_id=alpha:event:transition:1m38jag1eocj4w ## Scoped resources - `alpha://company/theravance-biopharma-inc` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record - `alpha://company/theravance-biopharma-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=identity - `alpha://company/theravance-biopharma-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=corporate-structure - `alpha://company/theravance-biopharma-inc/board` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=board - `alpha://company/theravance-biopharma-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=committees - `alpha://company/theravance-biopharma-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=leadership - `alpha://company/theravance-biopharma-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=ownership - `alpha://company/theravance-biopharma-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=financials - `alpha://company/theravance-biopharma-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=capital-structure - `alpha://company/theravance-biopharma-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=compensation - `alpha://company/theravance-biopharma-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=governance - `alpha://company/theravance-biopharma-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=shareholder-governance - `alpha://company/theravance-biopharma-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=audit - `alpha://company/theravance-biopharma-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=legal - `alpha://company/theravance-biopharma-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=risk - `alpha://company/theravance-biopharma-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=cyber - `alpha://company/theravance-biopharma-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=ai-governance - `alpha://company/theravance-biopharma-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=agents - `alpha://company/theravance-biopharma-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=ecosystem - `alpha://company/theravance-biopharma-inc/events` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=events - `alpha://company/theravance-biopharma-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=relationships - `alpha://company/theravance-biopharma-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=assessments - `alpha://company/theravance-biopharma-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Dean J. Mitchell: Director. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:5. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bc3c21436c720c5f79f1df069f969a5200c60af1ab1fd8daa28fa149271cba78. - Deepika R. Pakianathan: Director. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bc3c21436c720c5f79f1df069f969a5200c60af1ab1fd8daa28fa149271cba78. - Donal O’Connor: Director. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:7. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bc3c21436c720c5f79f1df069f969a5200c60af1ab1fd8daa28fa149271cba78. - Laurie Smaldone Alsup: Director. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:8. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bc3c21436c720c5f79f1df069f969a5200c60af1ab1fd8daa28fa149271cba78. - Susannah Gray: Director. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:9. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bc3c21436c720c5f79f1df069f969a5200c60af1ab1fd8daa28fa149271cba78. - Alan B. Miller: Senior Vice President, Development and Head of Ireland Office. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:10. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:032c609a9871aaac188b3298119bacd6ee248641ae4dbf841b82d14b252a2cb4. - Aziz Sawaf: Senior Vice President, Chief Financial Officer. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:11. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1077ca7f5037ed21caa2be961e1d49d5b94b456a8f67fc779134638cbd7aa668. - Brett A. Grimaud: Senior Vice President, General Counsel and Secretary. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:12. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5774780aa6a7ff34020144dcee044d22d4e83df79af46a5cc142fe1241b4cd71. - Rhonda F. Farnum: Chief Business Officer and Senior Vice President, Commercial Medical Affairs. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:13. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:78748888db210fe559fafaf6ffc59eb79eb07db0c694f421612752ec53544cb1. - Rick E Winningham: Chief Executive Officer and Director. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:leadership_role:14. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:682b2a0a58314bb1e29a0ba61d82cc4d985c08f63c3a3aa3f20f0eb953507cd0. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Theravance Biopharma, Inc.. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f89ddf4852d242da4e458ae6fd8c225fbb4dd65a529b092195e044c306741b41. ## Entity Status - Public listing published. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f89ddf4852d242da4e458ae6fd8c225fbb4dd65a529b092195e044c306741b41. ## Published Fact - US. Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f89ddf4852d242da4e458ae6fd8c225fbb4dd65a529b092195e044c306741b41. ## Security Listing - TBPH (NASDAQ). Claim: alpha:claim:company:a60efba0-8d4c-4112-abee-20c3b113c86f:security_listing:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f89ddf4852d242da4e458ae6fd8c225fbb4dd65a529b092195e044c306741b41. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:f89ddf4852d242da4e458ae6fd8c225fbb4dd65a529b092195e044c306741b41: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/theravance-biopharma-inc). - alpha:projection-evidence:document:bc3c21436c720c5f79f1df069f969a5200c60af1ab1fd8daa28fa149271cba78: [DEF 14A tm261413-1_def14a.htm](https://www.sec.gov/Archives/edgar/data/1583107/000110465926050454/tm261413-1_def14a.htm). - alpha:projection-evidence:document:032c609a9871aaac188b3298119bacd6ee248641ae4dbf841b82d14b252a2cb4: [TBPH DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1583107/000110465926050454/tm261413-1_def14a.htm). - alpha:projection-evidence:document:1077ca7f5037ed21caa2be961e1d49d5b94b456a8f67fc779134638cbd7aa668: [TBPH DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1583107/000110465926050454/tm261413-1_def14a.htm). - alpha:projection-evidence:document:5774780aa6a7ff34020144dcee044d22d4e83df79af46a5cc142fe1241b4cd71: [TBPH DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1583107/000110465926050454/tm261413-1_def14a.htm). - alpha:projection-evidence:document:78748888db210fe559fafaf6ffc59eb79eb07db0c694f421612752ec53544cb1: [TBPH DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1583107/000110465926050454/tm261413-1_def14a.htm). - alpha:projection-evidence:document:682b2a0a58314bb1e29a0ba61d82cc4d985c08f63c3a3aa3f20f0eb953507cd0: [TBPH DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1583107/000110465926050454/tm261413-1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/theravance-biopharma-inc) - [Public Markdown](https://registry.alpha.ac/companies/theravance-biopharma-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/theravance-biopharma-inc?format=jsonld) - MCP resource: `alpha://companies/theravance-biopharma-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-21T08:35:39.284173+00:00; recorded 2026-10-21T08:35:39.284173+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.